News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
247,163 Results
Type
Article (5838)
Company Profile (21)
Press Release (241304)
Multimedia
Podcasts (1)
Webinars (5)
Section
Business (87641)
Career Advice (470)
Deals (16476)
Drug Delivery (9)
Drug Development (21236)
Employer Resources (32)
FDA (4048)
Job Trends (4548)
News (129725)
Policy (8417)
Tag
Academia (337)
Accelerated approval (3)
Adcomms (3)
Allergies (10)
Alliances (16225)
ALS (28)
Alzheimer's disease (327)
Antibody-drug conjugate (ADC) (17)
Approvals (4078)
Artificial intelligence (63)
Autoimmune disease (8)
Automation (4)
Bankruptcy (107)
Best Places to Work (3387)
Biosimilars (19)
Biotechnology (28)
Bladder cancer (16)
Brain cancer (8)
Breast cancer (88)
Cancer (643)
Cardiovascular disease (33)
Career advice (402)
Career pathing (3)
CAR-T (44)
CDC (2)
Cell therapy (129)
Cervical cancer (2)
Clinical research (17956)
Collaboration (247)
Compensation (234)
Complete response letters (3)
COVID-19 (451)
CRISPR (13)
C-suite (161)
Cystic fibrosis (20)
Data (771)
Denatured (1)
Depression (12)
Diabetes (63)
Diagnostics (2273)
Digital health (4)
Diversity, equity & inclusion (14)
Drug discovery (30)
Drug pricing (9)
Drug shortages (2)
Duchenne muscular dystrophy (18)
Earnings (43357)
Editorial (2)
Employer branding (6)
Employer resources (34)
Events (40944)
Executive appointments (391)
FDA (4458)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (3)
Funding (281)
Gene editing (22)
Generative AI (2)
Gene therapy (60)
GLP-1 (139)
Government (511)
Guidances (94)
Healthcare (5574)
HIV (9)
Huntington's disease (3)
IgA nephropathy (8)
Immunology and inflammation (19)
Indications (9)
Infectious disease (472)
Inflammatory bowel disease (27)
Inflation Reduction Act (3)
Influenza (3)
Intellectual property (19)
Interviews (57)
IPO (8449)
IRA (3)
Job creations (1258)
Job search strategy (365)
Kidney cancer (9)
Labor market (5)
Layoffs (107)
Leadership (5)
Legal (2678)
Liver cancer (19)
Longevity (4)
Lung cancer (72)
Lymphoma (40)
Machine learning (1)
Management (11)
Manufacturing (79)
MASH (33)
Medical device (4323)
Medtech (4325)
Mergers & acquisitions (8356)
Metabolic disorders (163)
Multiple sclerosis (13)
NASH (6)
Neurodegenerative disease (16)
Neuropsychiatric disorders (2)
Neuroscience (476)
NextGen: Class of 2025 (1792)
Non-profit (792)
Now hiring (3)
Obesity (67)
Opinion (31)
Ovarian cancer (19)
Pain (20)
Pancreatic cancer (25)
Parkinson's disease (37)
Partnered (8)
Patents (39)
Patient recruitment (46)
Peanut (5)
People (26632)
Pharmaceutical (8)
Pharmacy benefit managers (2)
Phase I (5333)
Phase II (7916)
Phase III (6170)
Pipeline (808)
Policy (11)
Postmarket research (658)
Preclinical (2122)
Press Release (67)
Prostate cancer (41)
Psychedelics (5)
Radiopharmaceuticals (120)
Rare diseases (99)
Real estate (2015)
Recruiting (9)
Regulatory (5723)
Reports (18)
Research institute (352)
Resumes & cover letters (68)
Rett syndrome (8)
RNA editing (3)
Schizophrenia (32)
Series A (41)
Series B (31)
Service/supplier (2)
Sickle cell disease (8)
Special edition (1)
Spinal muscular atrophy (31)
Sponsored (5)
Startups (1127)
State (1)
Stomach cancer (1)
Supply chain (14)
Tariffs (5)
Vaccines (70)
Venture capital (4)
Weight loss (25)
Women's health (3)
Date
Today (32)
Last 7 days (125)
Last 30 days (567)
Last 365 days (10463)
2025 (5587)
2024 (12202)
2023 (14506)
2022 (20418)
2021 (21838)
2020 (19697)
2019 (14289)
2018 (10999)
2017 (10865)
2016 (9993)
2015 (13151)
2014 (10359)
2013 (8347)
2012 (9039)
2011 (9442)
2010 (9255)
Location
Africa (200)
Alabama (16)
Alaska (2)
Arizona (72)
Arkansas (1)
Asia (12264)
Australia (1689)
California (2470)
Canada (1294)
China (97)
Colorado (111)
Connecticut (110)
Delaware (49)
Europe (26182)
Florida (382)
Georgia (46)
Idaho (24)
Illinois (130)
India (7)
Indiana (95)
Iowa (7)
Japan (113)
Kansas (26)
Kentucky (14)
Louisiana (6)
Maine (43)
Maryland (264)
Massachusetts (2034)
Michigan (118)
Minnesota (166)
Mississippi (1)
Missouri (23)
Montana (16)
Nebraska (14)
Nevada (36)
New Hampshire (24)
New Jersey (869)
New Mexico (8)
New York (639)
North Carolina (399)
North Dakota (4)
Northern California (1180)
Ohio (75)
Oklahoma (8)
Oregon (4)
Pennsylvania (466)
Puerto Rico (2)
Rhode Island (14)
South America (307)
South Carolina (10)
Southern California (891)
Tennessee (54)
Texas (346)
United States (9299)
Utah (74)
Virginia (63)
Washington D.C. (15)
Washington State (212)
West Virginia (2)
Wisconsin (41)
247,163 Results for "sernova corp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Chair of Sernova Biotherapeutics Resigns
May 26, 2025
·
1 min read
Press Releases
Sernova Appoints Jonathan Rigby as Interim Chair
June 3, 2025
·
3 min read
Press Releases
Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes
July 10, 2025
·
5 min read
Press Releases
Sernova Announces Appointment of Ross Haghighat as Chair of the Board and a Change of Name to Sernova Biotherapeutics
January 30, 2025
·
4 min read
Press Releases
Sernova Corp. Announces Appointment of New Chief Executive Officer
August 12, 2024
·
5 min read
Press Releases
Sernova Biotherapeutics Secures $4 Million Loan to Further Advance its Clinical Development Plans
April 17, 2025
·
5 min read
Sernova Announces Additional Patient Insulin Independent and Cohort 2 Enrollment Complete in Ongoing Phase I/II Clinical Trial for Treatment of Type 1 Diabetes
Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage biotechnology company, today announces developments in its Phase I/II clinical trial investigating a novel treatment for Type 1 Diabetes (T1D). To date a total of 7 patients across Cohorts 1 and 2 have achieved insulin independence following transplants of human donor islets via Sernova’s proprietary Cell Pouch System™ and a marginal portal vein top up.
June 25, 2024
·
6 min read
Press Releases
Sernova Biotherapeutics Cell Pouch Bio-hybrid Organ to be Highlighted at Cell & Gene Meeting on the Med
April 15, 2025
·
2 min read
Press Releases
Sernova Update on Strategic Initiatives
December 3, 2024
·
4 min read
Press Releases
Sernova Biotherapeutics Secures $1 Million Convertible Debt Financing
March 5, 2025
·
2 min read
1 of 24,717
Next
